» Articles » PMID: 31904489

The Molecular Profile of Synovial Fluid Changes Upon Joint Distraction and is Associated with Clinical Response in Knee Osteoarthritis

Overview
Date 2020 Jan 7
PMID 31904489
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Surgical knee joint distraction (KJD) leads to clinical improvement in knee osteoarthritis (OA) and also apparent cartilage regeneration by magnetic resonance imaging. We investigated if alteration of the joint's mechanical environment during the 6 week period of KJD was associated with a molecular response in synovial fluid, and if any change was associated with clinical response.

Method: 20 individuals undergoing KJD for symptomatic radiographic knee OA had SF sampled at baseline, midpoint and endpoint of distraction (6 weeks). SF supernatants were measured by immunoassay for 10 predefined mechanosensitive molecules identified in our previous pre-clinical studies. The composite Knee injury and OA Outcome Score-4 (KOOS) was collected at baseline, 3, 6 and 12 months.

Results: 13/20 (65%) were male with mean age 54°±°5yrs. All had Kellgren-Lawrence grade ≥2 knee OA. 6/10 analytes showed statistically significant change in SF over the 6 weeks distraction (activin A; TGFβ-1; MCP-1; IL-6; FGF-2; LTBP2), P < 0.05. Of these, all but activin A increased. Those achieving the minimum clinically important difference of 10 points for KOOS over 6 months showed greater increases in FGF-2 and TGFβ-1 than non-responders. An increase in IL-8 during the 6 weeks of KJD was associated with significantly greater improvement in KOOS over 12 months.

Conclusion: Detectable, significant molecular changes are observed in SF following KJD, that are remarkably consistent between individuals. Preliminary findings appear to suggest that increases in some molecules are associated with clinically meaningful responses. Joint distraction may provide a potential opportunity in the future to define regenerative biomarker(s) and identify pathways that drive intrinsic cartilage repair.

Citing Articles

Development of methodology to support molecular endotype discovery from synovial fluid of individuals with knee osteoarthritis: The STEpUP OA consortium.

Deng Y, Perry T, Hulley P, Maciewicz R, Mitchelmore J, Perry D PLoS One. 2024; 19(11):e0309677.

PMID: 39556578 PMC: 11573211. DOI: 10.1371/journal.pone.0309677.


Changes and associations between synovial fluid and magnetic resonance imaging markers of osteoarthritis after high tibial osteotomy.

Schulz J, Birmingham T, Philpott H, Appleton C, Atkinson H, Giffin J Arthritis Res Ther. 2024; 26(1):176.

PMID: 39390512 PMC: 11465750. DOI: 10.1186/s13075-024-03409-3.


Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine.

Duo Y, Han L, Yang Y, Wang Z, Wang L, Chen J Chem Rev. 2024; 124(20):11242-11347.

PMID: 39380213 PMC: 11503637. DOI: 10.1021/acs.chemrev.4c00244.


Development of scaffold-free tissue-engineered constructs derived from mesenchymal stem cells with serum-free media for cartilage repair and long-term preservation.

Maeda S, Matsumoto M, Segawa K, Iwamoto K, Nakamura N Cytotechnology. 2024; 76(5):595-612.

PMID: 39188648 PMC: 11344744. DOI: 10.1007/s10616-024-00637-y.


Two-year post-distraction cartilage-related structural improvement is accompanied by increased serum full-length SIRT1.

Marco M, Jansen M, van der Weiden G, Reich E, Maatuf Y, Mastbergen S Arthritis Res Ther. 2024; 26(1):106.

PMID: 38790038 PMC: 11127335. DOI: 10.1186/s13075-024-03342-5.


References
1.
Nicholls E, Thomas E, van der Windt D, Croft P, Peat G . Pain trajectory groups in persons with, or at high risk of, knee osteoarthritis: findings from the Knee Clinical Assessment Study and the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2014; 22(12):2041-50. PMC: 4256061. DOI: 10.1016/j.joca.2014.09.026. View

2.
Altman R, Block D, Brandt K, Cooke D, Greenwald R, Hochberg M . Osteoarthritis: definitions and criteria. Ann Rheum Dis. 1990; 49(3):201. PMC: 1004025. DOI: 10.1136/ard.49.3.201-a. View

3.
Sawaji Y, Hynes J, Vincent T, Saklatvala J . Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum. 2008; 58(11):3498-509. DOI: 10.1002/art.24025. View

4.
Alexander S, Watt F, Sawaji Y, Hermansson M, Saklatvala J . Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB. Arthritis Rheum. 2007; 56(11):3715-25. DOI: 10.1002/art.22953. View

5.
Intema F, Thomas T, Anderson D, Elkins J, Brown T, Amendola A . Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis Cartilage. 2011; 19(6):668-75. PMC: 3097273. DOI: 10.1016/j.joca.2011.02.005. View